<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This Schedule Contains Summary Financial Information Extracted From
Form 10-Q For The Quarterly Period Ended June 30, 2000, And Is
Qualified In Its Entirety By Reference To Such Financial Statements
</LEGEND>
<MULTIPLIER> 1,000,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 1,715
<SECURITIES> 43
<RECEIVABLES> 5,937<F1>
<ALLOWANCES> 0
<INVENTORY> 4,112
<CURRENT-ASSETS> 12,485
<PP&E> 34,481
<DEPRECIATION> 20,310
<TOTAL-ASSETS> 40,237
<CURRENT-LIABILITIES> 10,656
<BONDS> 6,638
0
237
<COMMON> 340
<OTHER-SE> 12,670
<TOTAL-LIABILITY-AND-EQUITY> 40,237
<SALES> 15,507
<TOTAL-REVENUES> 16,073
<CGS> 9,884<F2>
<TOTAL-COSTS> 13,338<F3>
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 411
<INCOME-PRETAX> 2,324
<INCOME-TAX> 794
<INCOME-CONTINUING> 1,491
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 1,491
<EPS-BASIC> 1.42
<EPS-DILUTED> 1.41
<FN>
<F1>Includes Other Accounts In Addition To Notes and Accounts
Receivable-Trade.
<F2>Includes Other Operating Charges.
<F3>Cost of Goods Sold and Other Operating Charges; Depreciation;
Amortization of Goodwill and Other Intangible Assets; Research and
Development Expense; Selling, General and Administrative Expenses;
Purchased In-Process Research and Development; and Employee
Separation Costs and Write-Down of Assets.
</FN>
</TABLE>